Biotech

All Articles

Lilly- backed weight loss biotech data IPO

.After raising $170 thousand back in February, metabolic disease-focused BioAge Labs has filed to de...

Aelis' cannabis use medication flunks stage 2b, steering Indivior to reassess $100M possibility

.Aelis Farma's hopes of securing an easy, good decision on a $one hundred thousand possibility settl...

ProKidney stops stage 3 trial not needed to have for cell treatment authorization

.ProKidney has actually stopped among a pair of phase 3 tests for its own cell therapy for renal con...

Vaxcyte climbs on 'sensational' 31-valent PCV gain against Pfizer

.Vaxcyte revealed what analysts referred to as "spectacular" period 1/2 information for its 31-valen...

Recursion's human brain condition trial reveals insufficient evidence of effectiveness

.Recursion has actually discovered by means of an early test of its own tech-enabled strategy to dru...

Acepodia, Pfizer click on together for chemistry-based cell treatment

.Call it a case of good chemistry: Acepodia, a biotech based on Nobel Champion scientific research, ...

Praxis epilepsy medication decreases confiscations in phase 2 litigation

.Practice Preciseness Medicines has scored an additional midphase gain in epilepsy this year, along ...

Three officers surrender as Dyne blog posts blended records for DMD applicant

.After running away a clinical grip a number of years back, Dyne Therapeutics has actually exposed b...

Arrowhead fires off period 3 information in uncommon metabolic health condition in front of market encounter Ionis

.Arrowhead Pharmaceuticals has actually presented its own give in front of a possible showdown along...

Pfizer, Valneva show lyme health condition chance reliable for 2nd booster

.Pfizer and Valneva might have about 2 more years to hang around prior to they help make the first c...